: "But what neither plan deals with is the escalating costs of prescription drugs and the questionable practices by drug manufacturers aimed at keeping those costs - and their resulting profits - high. Legal reforms talked about so much during the last congressional campaigns, which would have reduced costs by forcing drug companies to spend less on advertising and by making the criteria for releasing generic, less costly versions of the same drugs to the public less stringent, have been forgotten in all this new rhetoric. "